RocaJunyent advises on the IPO of Axon Partners Group
- BME Growth approves Axon Partners Group's listing document.
- The placement, of up to 15 million, is aimed at institutional investors and family offices.
"The IPO will make the company even stronger and accelerate its growth by leveraging the firm's unique positioning in all of its business units," says Axon's chairman.
Axon Partner Group has already been given the green light for its IPO on BME Growth through an IPO (Initial Public Offering) with which the global strategic consulting and alternative investments firm will place 15% of its share capital.
Axon Partners Group has worked with different law firms during the process. In this case, RocaJunyent has advised the underwriters JB Capital Markets and GVC Gaesco. The case has been led by Jaime Tarrero and Mariano Renedo, partner and Capital Markets lawyer.
As the three directors of the group said, the Spanish fund manager plans to double in size in four years and "democratise" the company, giving employees, investors and clients a stake in the capital with a commitment to pay out 75% of the net profit in dividends.
